Funding for this research was provided by:
National Natural Science Foundation of China (No. 82173051)
Joint Funds for the Innovation of Science and Technology, Fujian province (No. 2019Y9036)
Scientific Research Foundation of Fujian Cancer Hospital (No.2021YN01)
Received: 19 April 2022
Accepted: 9 June 2022
First Online: 18 July 2022
: This present retrospective study was approved by the Fujian Province Cancer Hospital Institutional Review Board (Approval No. K2022-031-01).
: Consent for scientific usage of clinical data was obtained from all patients included in the study.
: The authors declare that they have no competing interests.